Risks of rapid change in blood glucose.
You are about to be started on a GLP-1 analog (tirzepatide/Mounjaro, Ozempic/semaglutide) /insulin /hybrid closed-loop pump
This is important for getting your blood sugars under better control and in the long-term will protect you from worsening eye disease (retinopathy), nerve disease (neuropathy), kidney disease (nephropathy). However when we tighten control, occasionally your eye disease can get worse before it gets better. This is because your blood vessels have been used to high blood sugars for a period of time and it will take some time to adapt to better blood sugar control. Our current understanding is that the risk is small but occasionally can cause bleeding and worsening of your vision.
There is absolutely no doubt that in the long-term better blood sugar control is protective for your eyes, nerves and kidneys.

Risk of progression of retinopathy
Tiny blood vessels at the back of the eye ( Retina) are very sensitive to blood flow. If these blood vessels are used to high blood sugars over a long period of time, they can adjust to high blood sugars. If we improve control rapidly, this can result in reduced blood circulation and new tiny blood vessels can grow. It can also lead to swelling at the back of the eye ( Maculopathy).
Risk of hypoglycemia
When control is tightened, you can have more pronounced drop in blood sugars. This is a hypoglycemia. ( when your sugars drop below 4.0 mmol/l ). This can occur unexpectedly or after exercise. One should be particularly careful when driving and monitor carefully as advised by DVLA. these rules are your blood sugars should be above 5.0 mmol/l to start driving You should check every 2 hours into a long drive You should carry short acting carbohydrates in the car within easy reach If you do have a hypoglycemic episode, you should stop driving and avoid driving for at least 45 minutes DVLA Rules –
please refer to DVLA website for up-to-date info
What should I do?
- Understand that there is increased risk of progression of retinopathy. We can mitigate risks but cannot eliminate this risk completely
- Please ensure that your eye screening is uptodate and share your result with your diabetes team
- If you are waiting for Eye hospital appointment, please chase this up. This is your responsibility
- This risk is maximal in the first few months after commencing treatment. Please be vigilant and notify the team if you are concerned.
- If you notice any change in vision, please contact eye hospital
Trials are ongoing to determine this risk and we should have more information by 2027